Gregory Bailey
CIK 1329505 · last filed 2026-06-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$31.24M
Companies
6
Total Filings
92
Lifetime Open-Market Net
-$43.45M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SER | Director | 1,897,445 | $2.05 | $3.89M | $504.8K | 16 | 2026-06-22 |
| BHVN | Director | 2,020,071 | $13.54 | $27.35M | -$23.12M | 35 | 2025-11-17 |
| Serina Therapeutics, Inc. (AGE) Delisted | Director | — | $11.10 | — | $0 | 2 | 2021-06-23 |
| MEDIVATION, INC. (MDVN) Delisted | Director | 2,421,486 | — | — | -$20.84M | 34 | 2012-11-01 |
| Acer Therapeutics Inc. (OPXAW) Delisted | Director | 131,000 | — | — | $0 | 2 | 2008-06-30 |
| Acer Therapeutics Inc. (OPXA) Delisted | Director | — | — | — | $0 | 1 | 2007-06-21 |
Recent Filings · Page 5 of 10
92 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-05-01 | BHVN | Grant (A) | — | $0 | EDGAR |
| 2019-08-21 | BHVN | Buy (P) | +5,000 | $188.2K | EDGAR |
| 2019-05-23 | BHVN | Grant (A) | — | $0 | EDGAR |
| 2019-04-05 | BHVN | Exer (M) | +107,500 | $998.7K | EDGAR |
| 2019-03-13 | Serina Therapeutics, Inc. (AGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-03 | BHVN | Grant (A) | — | $0 | EDGAR |
| 2018-02-02 | BHVN | Sell (S) | −50,000 | -$1.69M | EDGAR |
| 2018-01-25 | BHVN | Sell (S) | −16,000 | -$524.6K | EDGAR |
| 2018-01-23 | BHVN | Sell (S) | −49,000 | -$1.51M | EDGAR |
| 2018-01-18 | BHVN | Sell (S) | −40,000 | -$1.06M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.